Key Decisions and Quantitative Figures

1. Fundraising via Preferential Issue:

  • The Board considered and approved fundraising through a preferential issue of equity shares and other convertible instruments.
  • The aggregate consideration for this fundraising is approved for an amount not exceeding ₹110,00,00,000/- (Rupees One Hundred Ten Crore Only).
  • This approval is subject to shareholder approval and other necessary statutory, regulatory, and governmental approvals.
  • Specific details including the type of securities, issue price, number of securities, proposed allottees, and other terms are to be determined and approved by the Board at a subsequent meeting.
  • The final terms will be set in accordance with the Companies Act, 2013, the SEBI ICDR Regulations, and other applicable laws.

2. Broad Fundraising Approval:

  • The Board approved raising funds through all permitted instruments for an amount not exceeding USD 25 Million (US Dollar Twenty Five millions) or its equivalent in Indian Rupees or other foreign currencies.
  • Permitted instruments include equity shares (for cash or other than cash), convertible bonds, debentures, warrants, preference shares, foreign currency convertible bonds (FCCB), share swaps, any other equity-linked securities, or any other securities.
  • Methods can include preferential issue on a private placement basis, qualified institutional placement (QIP) including share swap, or any other methods or combinations thereof, for listed or unlisted securities.
  • The fundraising may be conducted in one or more tranches.
  • Terms and conditions, including security, rate of interest, and discount, are to be determined by the Board at its absolute discretion, subject to required shareholder, regulatory, and statutory approvals.

3. Appointment of Secretarial Auditor:

  • The Board appointed M/s Jigar Trivedi & Co, a Peer Reviewed Firm of Practicing Company Secretaries, as the Secretarial Auditor of the Company.
  • This appointment fills a casual vacancy arising from the resignation of the previous Secretarial Auditor.
  • The term of appointment is effective from November 17, 2026, and will last until the conclusion of the ensuing Annual General Meeting of the Company, in accordance with Regulation 24A(1)(c) of the SEBI LODR Regulations, 2015.
  • The firm's profile includes expertise in Corporate Laws, Securities Laws, SEBI Regulations, and other statutory and regulatory compliances, including conducting Secretarial Audits.

Financial and Operational Impact

The financial impact of the proposed fundraising is potential capital inflow of up to ₹110 crore (via preferential issue) and up to USD 25 million (via other methods). The specific impact on capital structure, including potential dilution, will be determined upon finalization of the issue terms and is subject to approvals. The appointment of a new auditor is an operational governance change.

Dates and Parties Involved

  • Board Meeting Date: November 17, 2026 (5:30 PM to 7:00 PM).
  • Appointment Effective Date: November 17, 2026.
  • Regulatory Authority: SEBI, BSE.
  • Entities Involved: Looks Health Services Limited, M/s Jigar Trivedi & Co.